Novo Nordisk A/S (NYSE:NVO)

53.84
Delayed Data
As of Mar 27
 +0.58 / +1.09%
Today’s Change
41.72
Today|||52-Week Range
54.38
+27.22%
Year-to-Date

Today’s Trading

Previous close53.26
Today’s open53.77
Day’s range53.09 - 53.92
Volume7,025,729
Average volume (3 months)1,559,696
Market cap$110.4B
Dividend yield1.41%
Data as of 4:03pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.32%
Revenue growth (last year)+5.60%
P/E ratio5.3
Price/Sales7.05
Price/Book21.32

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.26+0.40%
GSKGlaxoSmithKline+0.36+0.77%
ACTActavis+2.24+0.74%
CELGCelgene+1.02+0.87%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.51
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account